Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study

BACKGROUND: Severe exacerbations requiring hospitalization contribute a substantial portion of the morbidity and costs of chronic obstructive pulmonary disease (COPD). Triple therapy (inhaled corticosteroid + long-acting β-agonist + long-acting muscarinic antagonist) is a recommended option for pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Kristin A, Pollack, Michael, Portillo, Edward, Strange, Charlie, Touchette, Daniel R, Staresinic, Anthony, Patel, Sushma, Tkacz, Joseph, Feigler, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372961/
https://www.ncbi.nlm.nih.gov/pubmed/36427341
http://dx.doi.org/10.18553/jmcp.2022.28.12.1366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372961/
https://www.ncbi.nlm.nih.gov/pubmed/36427341
http://dx.doi.org/10.18553/jmcp.2022.28.12.1366

Ejemplares similares